1. Introducing the TRUMPET project:TRUstworthy Multi-site Privacy Enhancing Technologies
- Author
-
Pedrouzo-Ulloa, A. (Alberto), Ramon, J. (Jan), Duflot, P. (Patrick), Pérez-González, F. (Fernando), Lilova, S. (Siyanna), Chihani, Z. (Zakaria), Gentili, N. (Nicola), Ulivi, P. (Paola), Hoque, M.A. (Mohammad Ashadul), Mukammel, T. (Twaha), Pritzker, Z. (Zeev), Lemesle, A. (Augustin), Loureiro-Acuña, J. (Jaime), Martı́nez, X. (Xavier), Jiménez-Balsa, G. (Gonzalo), Universidade de Vigo, Machine Learning in Information Networks [MAGNET], Centre Hospitalier Universitaire de Liège [CHU-Liège], Timelex, Laboratoire d'Intégration des Systèmes et des Technologies [LIST (CEA)], Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Technovative Solutions, Arteevo Technologies, and Centro Tecnoloxico de Telecomunicacions de Galicia [Gradiant]
- Subjects
Federated Learning Privacy Metrics Privacy Enhancing Technologies General Data Protection Regulation Clinical Cancer Research Patient Data Privacy ,Federated Learning ,Privacy Metrics ,Privacy Enhancing Technologies ,General Data Protection Regulation ,Clinical Cancer Research ,Patient Data Privacy - Abstract
This paper is an overview of the EU-funded project TRUMPET (https://trumpetproject.eu/), and gives an outline of its scope and main technical aspects and objectives. In recent years, Federated Learning has emerged as a revolutionary privacy-enhancing technology. However, further research has cast a shadow of doubt on its strength for privacy protection. The goal of TRUMPET is to research and develop novel privacy enhancement methods for Federated Learning, and to deliver a highly scalable Federated AI service platform for researchers, that will enable AI-powered studies of siloed, multi-site, crossdomain, cross-border European datasets with privacy guarantees that follow the requirements of GDPR. The generic TRUMPET platform will be piloted, demonstrated and validated in the specific use case of European cancer hospitals, allowing researchers and policymakers to extract AI-driven insights from previously inaccessible cross-border, cross-organization cancer data, while ensuring the patients' privacy.
- Published
- 2023